Using lineage-tracing and functional approaches in vivo, the authors showed that p63+ cells arising from the lung primordium are initially multipotent progenitors of airway and alveolar lineages, but later become restricted proximally to generate the tracheal adult stem cell pool. [Dev Cell]
Full Article | Graphical Abstract

ARMO BioSciences, Inc. announced enrollment of its first patient in CYPRESS 2, a randomized Phase IIb trial designed to investigate pegilodecakin (AM0010) in combination with nivolumab as a second-line treatment for patients with metastatic non-small cell lung cancer. [ARMO BioSciences, Inc.]
Press Release

University of Toronto Medicine Professor Frances Shepherd — an innovator in the study and treatment of lung cancer — has won the 2018 Canada Gairdner Wightman Award for outstanding career leadership in medicine and medical science. [University of Toronto]
Press Release

Late last year, National Institutes of Health (NIH) officials disclosed that they had discovered that someone involved in the proposal review process had violated confidentiality rules designed to protect its integrity. As a result, the agency announced in December 2017 that it would re-review dozens of applications that might have been compromised. Now, NIH says it has completed re-evaluating 60 applications and has also begun taking disciplinary action against researchers who broke its rules. [ScienceInsider]
Editorial

India has a new science adviser. Prime Minister Narendra Modi’s government tapped Krishnaswamy VijayRaghavan, a molecular biologist and head of India’s Department of Biotechnology, to fill the post. [ScienceInsider]
Editorial